Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Midatech Platforms Will Drive Specialty Pharma Share Of Voice

Executive Summary

Specialty pharma has been one of the hottest growth areas in recent years but with many companies entering into the space it is now a crowded marketplace. Speaking at Biotech Showcase 2018, Midatech Pharma CEO Jim Phillips told Scrip how the company’s three proprietary drug delivery platforms will underpin its ambitions to gain share of voice in the US and beyond, while outlining the prospects for its current pipeline.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC100533

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel